Terms: = Pancreatic cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Prognosis
4 results:
1. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
2. Relationship between cellular morphology and abnormality of SWI/SNF complex subunits in pancreatic undifferentiated carcinoma.
Yamamoto T; Kohashi K; Yamada Y; Kawata J; Sakihama K; Matsuda R; Koga Y; Aishima S; Nakamura M; Oda Y
J Cancer Res Clin Oncol; 2022 Nov; 148(11):2945-2957. PubMed ID: 34817661
[TBL] [Abstract] [Full Text] [Related]
3. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.
Takeuchi S; Doi M; Ikari N; Yamamoto M; Furukawa T
Sci Rep; 2018 May; 8(1):8105. PubMed ID: 29802286
[TBL] [Abstract] [Full Text] [Related]
4. The clinical significance of SWI/SNF complex in pancreatic cancer.
Numata M; Morinaga S; Watanabe T; Tamagawa H; Yamamoto N; Shiozawa M; Nakamura Y; Kameda Y; Okawa S; Rino Y; Akaike M; Masuda M; Miyagi Y
Int J Oncol; 2013 Feb; 42(2):403-10. PubMed ID: 23229642
[TBL] [Abstract] [Full Text] [Related]